1
|
Bharmal M, DiGrande K, Patel A, Shavelle DM, Bosson N. Impact of Coronavirus Disease 2019 Pandemic on Cardiac Arrest and Emergency Care. Cardiol Clin 2024; 42:307-316. [PMID: 38631797 DOI: 10.1016/j.ccl.2024.02.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 04/19/2024]
Abstract
The incidence of both out-of-hospital and in-hospital cardiac arrest increased during the coronavirus disease 2019 (COVID-19) pandemic. Patient survival and neurologic outcome after both out-of-hospital and in-hospital cardiac arrest were reduced. Direct effects of the COVID-19 illness combined with indirect effects of the pandemic on patient's behavior and health care systems contributed to these changes. Understanding the potential factors offers the opportunity to improve future response and save lives.
Collapse
Affiliation(s)
- Murtaza Bharmal
- Department of Cardiology, University of California Irvine Medical Center, 510 E Peltason Drive, Irvine, CA 92697, USA
| | - Kyle DiGrande
- Department of Cardiology, University of California Irvine Medical Center, 510 E Peltason Drive, Irvine, CA 92697, USA
| | - Akash Patel
- Department of Cardiology, University of California Irvine Medical Center, 510 E Peltason Drive, Irvine, CA 92697, USA
| | - David M Shavelle
- MemorialCare Heart and Vascular Institute, Long Beach Medical Center, 2801 Atlantic Avenue, Long Beach, CA 90807, USA
| | - Nichole Bosson
- Los Angeles County Emergency Medical Services Agency, 10100 Pioneer Boulevard Ste 200, Santa Fe Springs, CA 90670, USA; Department of Emergency Medicine, Harbor-UCLA Medical Center, 1000 W Carson Street, Torrance, CA, 90509, USA; David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA.
| |
Collapse
|
2
|
Choi HK, Maity M, Qureshi M, Haider A, Kapadia S, Fuerte S, Antony S, Razzaq W, Akbar A. Multifaceted Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on ST-Elevation Myocardial Infarction (STEMI): A Literature Review of Incidence, Treatment Modalities, and Outcomes. Cureus 2024; 16:e57288. [PMID: 38690470 PMCID: PMC11059148 DOI: 10.7759/cureus.57288] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/30/2024] [Indexed: 05/02/2024] Open
Abstract
The global repercussions of coronavirus disease 2019 (COVID-19) include substantial worldwide mortality and have brought to light existing gaps in healthcare systems. Particularly, diseases requiring time-sensitive treatment, such as ST-elevation myocardial infarction (STEMI), have faced significant challenges due to the impact and revelations of the COVID-19 pandemic on healthcare infrastructure. This review addresses the impact of the pandemic on STEMI, exploring incidence, treatment modalities, and clinical outcomes. Through a critical examination of existing literature, the intricate relationship between the pandemic and cardiovascular health, specifically STEMI, is elucidated. The COVID-19 pandemic has had a significant impact on the management of STEMI, with changes in hospitalization rates, treatment strategies, and the presentation of the disease posing significant challenges. The contradictory results of COVID-19 and post-vaccine myocardial infarction, as well as gender differences in reported cases, highlight the need for further research to clarify these relationships.
Collapse
Affiliation(s)
- Hoi K Choi
- Internal Medicine, University of Michigan, Ann Arbor, USA
| | - Madhurima Maity
- Internal Medicine, Sir H. N. Reliance Foundation Hospital and Research Centre, Mumbai, IND
| | - Mohammed Qureshi
- Internal Medicine, American University of the Caribbean School of Medicine, Cupecoy, SXM
| | - Ali Haider
- Medicine, Quetta Institute of Medical Sciences, Quetta, PAK
| | | | - Sofia Fuerte
- Internal Medicine, Instituto Tecnológico y de Estudios Superiores de Monterrey, Monterrey, MEX
| | - Simon Antony
- Internal Medicine, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND
| | | | - Anum Akbar
- Pediatrics, University of Nebraska Medical Center, Omaha, USA
| |
Collapse
|
3
|
Babeluk R, Maier B, Bach T, Hajdu S, Jaindl M, Antoni A. The Hidden Pandemic: Impact of the COVID-19 Pandemic on Trauma Cases Due to Domestic Violence Admitted to the Biggest Level-One Trauma Center in Austria. J Clin Med 2023; 13:246. [PMID: 38202253 PMCID: PMC10779589 DOI: 10.3390/jcm13010246] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2023] [Revised: 12/21/2023] [Accepted: 12/29/2023] [Indexed: 01/12/2024] Open
Abstract
BACKGROUND An alarming increase in domestic violence was reported during the COVID-19 pandemic worldwide. The aim of this study is to investigate changes in the frequency and the nature of domestic violence at the largest level-one trauma center in Austria. METHODS All patients admitted to our institution with domestic violence injuries 15 months before and after the beginning of the COVID-19 pandemic were included. For our analysis, we investigated the frequency of trauma patients after domestic violence in relation to all other trauma patients. Furthermore, age, sex, citizenship, injury pattern, injured body regions, injury mechanism, offender-victim relationship, and hospitalization rate were also analyzed. RESULTS Among all trauma patients admitted, the ratio of patients who reported domestic violence injuries increased from 0.465% to 0.548% since the start of the pandemic. In addition, out of the total count of domestic violence victims, the percentage of Austrian citizens increased significantly from 51.2% to 60.6% (p = 0.016). All other parameters showed no significant changes pre and post-pandemic. CONCLUSION The COVID-19 pandemic contributed to a relative increase in patients with domestic violence injuries at the largest trauma unit in Austria, along with a significant increase among Austrian citizens. The remaining study parameters did not differ significantly, indicating that the frequency changed during the pandemic but not the underlying pattern of domestic violence.
Collapse
Affiliation(s)
- Rita Babeluk
- Division of Trauma Surgery, Department of Orthopedics and Trauma Surgery, Medical University of Vienna, Waehringer Gürtel 18-20, 1090 Vienna, Austria; (B.M.); (T.B.)
| | | | | | | | | | | |
Collapse
|
4
|
Bharmal M, DiGrande K, Patel A, Shavelle DM, Bosson N. Impact of Coronavirus Disease 2019 Pandemic on Cardiac Arrest and Emergency Care. Heart Fail Clin 2023; 19:231-240. [PMID: 36863815 PMCID: PMC9973546 DOI: 10.1016/j.hfc.2022.08.009] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/04/2023]
Abstract
The incidence of both out-of-hospital and in-hospital cardiac arrest increased during the coronavirus disease 2019 (COVID-19) pandemic. Patient survival and neurologic outcome after both out-of-hospital and in-hospital cardiac arrest were reduced. Direct effects of the COVID-19 illness combined with indirect effects of the pandemic on patient's behavior and health care systems contributed to these changes. Understanding the potential factors offers the opportunity to improve future response and save lives.
Collapse
Affiliation(s)
- Murtaza Bharmal
- Department of Cardiology, University of California Irvine Medical Center, 510 E Peltason Drive, Irvine, CA 92697, USA
| | - Kyle DiGrande
- Department of Cardiology, University of California Irvine Medical Center, 510 E Peltason Drive, Irvine, CA 92697, USA
| | - Akash Patel
- Department of Cardiology, University of California Irvine Medical Center, 510 E Peltason Drive, Irvine, CA 92697, USA
| | - David M Shavelle
- MemorialCare Heart and Vascular Institute, Long Beach Medical Center, 2801 Atlantic Avenue, Long Beach, CA 90807, USA
| | - Nichole Bosson
- Los Angeles County Emergency Medical Services Agency, 10100 Pioneer Boulevard Ste 200, Santa Fe Springs, CA 90670, USA; Department of Emergency Medicine, Harbor-UCLA Medical Center, 1000 W Carson Street, Torrance, CA, 90509, USA; David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA.
| |
Collapse
|
5
|
Mousavi RA, Roth D, Wallmüller C, Pichler G, Stratil P, Schreiber W, Delle-Karth G, Schober A. Effect of Austrian COVID-19 lockdowns on acute myocardial infarction frequency and long-term mortality: a multicentre observational study. BMJ Open 2023; 13:e065308. [PMID: 36754558 PMCID: PMC9922876 DOI: 10.1136/bmjopen-2022-065308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/10/2023] Open
Abstract
OBJECTIVES The aim of this study was to find out if the decrease in acute myocardial infarction (AMI) admissions during the first COVID-19 lockdowns (LD), which was described by previous studies, occurred equally in all LD periods (LD1, LD2, LD2021), which had identical restrictions. Further, we wanted to analyse if the decrease of AMI admission had any association with the 1-year mortality rate. DESIGN AND SETTING This study is a prospective observational study of two centres that are participating in the Vienna ST-elevation myocardial infarction network. PARTICIPANTS A total of 1732 patients who presented with AMI according to the 4th universal definition of myocardial infarction in 2019, 2020 and the LD period of 2021 were included in our study. Patients with myocardial infarction with non-obstructive coronary arteries were excluded from our study. MAIN OUTCOME MEASURES The primary outcome of this study was the frequency of AMI during the LD periods and the all-cause and cardiac-cause 1-year mortality rate of 2019 (pre-COVID-19) and 2020. RESULTS Out of 1732 patients, 70% (n=1205) were male and median age was 64 years. There was a decrease in AMI admissions of 55% in LD1, 28% in LD2 and 17% in LD2021 compared with 2019.There were no differences in all-cause 1-year mortality between the year 2019 (11%; n=110) and 2020 (11%; n=79; p=0.92) or death by cardiac causes [10% (n=97) 2019 vs 10% (n=71) 2020; p=0.983]. CONCLUSION All LDs showed a decrease in AMI admissions, though not to the same extent, even though the regulatory measures were equal. Admission in an LD period was not associated with cardiac or all-cause 1-year mortality rate in AMI patients in our study.
Collapse
Affiliation(s)
- Roya Anahita Mousavi
- Karl Landsteiner Institute for Cardiovascular and Critical Care Research, Vienna, Austria
| | - Dominik Roth
- Department of Emergency Medicine, Medical University of Vienna, Vienna, Austria
| | - Christian Wallmüller
- Karl Landsteiner Institute for Cardiovascular and Critical Care Research, Vienna, Austria
- Department of Cardiology, Clinic Floridsdorf, Vienna, Austria
| | - Gernot Pichler
- Karl Landsteiner Institute for Cardiovascular and Critical Care Research, Vienna, Austria
- Department of Cardiology, Clinic Floridsdorf, Vienna, Austria
| | - Peter Stratil
- Karl Landsteiner Institute for Cardiovascular and Critical Care Research, Vienna, Austria
- Department of Cardiology, Clinic Floridsdorf, Vienna, Austria
| | - Wolfgang Schreiber
- Department of Emergency Medicine, Medical University of Vienna, Vienna, Austria
| | - Georg Delle-Karth
- Karl Landsteiner Institute for Cardiovascular and Critical Care Research, Vienna, Austria
- Department of Cardiology, Clinic Floridsdorf, Vienna, Austria
| | - Andreas Schober
- Karl Landsteiner Institute for Cardiovascular and Critical Care Research, Vienna, Austria
- Department of Cardiology, Clinic Floridsdorf, Vienna, Austria
| |
Collapse
|
6
|
Kaziród-Wolski K, Zając P, Zabojszcz M, Kołodziej A, Sielski J, Siudak Z. The Effect of COVID-19 on the Perioperative Course of Acute Coronary Syndrome in Poland: The Estimation of Perioperative Prognosis and Neural Network Analysis in 243,515 Cases from 2020 to 2021. J Clin Med 2022; 11:jcm11185394. [PMID: 36143039 PMCID: PMC9506468 DOI: 10.3390/jcm11185394] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2022] [Revised: 09/09/2022] [Accepted: 09/10/2022] [Indexed: 12/03/2022] Open
Abstract
COVID-19 causes thromboembolic complications that affect the patient’s prognosis. COVID-19 vaccines significantly improve the prognosis for the course of the infection. The aim of this study was to evaluate the impacts of patient characteristics, including COVID-19 vaccinations, on perioperative mortality in acute coronary syndrome in Poland during the pandemic. We analyzed the data of 243,515 patients from the National Registry of Invasive Cardiology Procedures (Ogólnopolski Rejestr Procedur Kardiologii Inwazyjnej [ORPKI]). In this group, 7407 patients (21.74%) had COVID-19. The statistical analysis was based on a neural network that was verified by the random forest method. In 2020, the most significant impact on prognosis came from a diagnosis of unstable angina, a short period (<2 h) from pain occurrence to first medical contact, and a history of stroke. In 2021, the most significant factors were pre-hospital cardiac arrest, female sex, and a short period (<2 h) from first medical contact to coronary angiography. After adjusting for a six-week lag, a diagnosis of unstable angina and psoriasis were found to be relevant in the data from 2020, while in 2021, it was the time from the pain occurrence to the first medical contact (2−12 h) in non-ST segment elevation myocardial infarction and the time from first contact to balloon inflation (2−12 h) in ST-segment elevation myocardial infarction. The number of vaccinations was one of the least significant factors. COVID-19 vaccination does not directly affect perioperative prognosis in patients with acute coronary syndrome.
Collapse
Affiliation(s)
- Karol Kaziród-Wolski
- Collegium Medicum, Jan Kochanowski University in Kielce, al. IX Wieków Kielc 19A, 25-369 Kielce, Poland
- Correspondence:
| | - Patrycja Zając
- The Reumatology Department of the Province Hospital in Konskie, ul. Gimnazjalna 41B, 26-200 Konskie, Poland
| | - Michał Zabojszcz
- Collegium Medicum, Jan Kochanowski University in Kielce, al. IX Wieków Kielc 19A, 25-369 Kielce, Poland
| | - Agnieszka Kołodziej
- Collegium Medicum, Jan Kochanowski University in Kielce, al. IX Wieków Kielc 19A, 25-369 Kielce, Poland
| | - Janusz Sielski
- Collegium Medicum, Jan Kochanowski University in Kielce, al. IX Wieków Kielc 19A, 25-369 Kielce, Poland
| | - Zbigniew Siudak
- Collegium Medicum, Jan Kochanowski University in Kielce, al. IX Wieków Kielc 19A, 25-369 Kielce, Poland
| |
Collapse
|
7
|
Impact of COVID-19 Pandemic on Cardiac Arrest and Emergency Care. Cardiol Clin 2022; 40:355-364. [PMID: 35851459 PMCID: PMC8960232 DOI: 10.1016/j.ccl.2022.03.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/04/2022]
|
8
|
TANDA E, CASULA M, RUIU G, ZAPPADU S, GENADIEV GG, CAMPARINI S, SANFILIPPO R. Hospitalization rate and treatment strategy for critical limb ischemia in south Sardinia during COVID-19. ITALIAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY 2022. [DOI: 10.23736/s1824-4777.21.01527-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
9
|
Ponde C, Jain D, Suresh M, Gunasekaran S, Mishra S, Alexander T, Nair T. Impact of COVID-19 pandemic induced lockdown on management of myocardial infarction: An Indian survey report from the experiences by 1083 cardiologists. JOURNAL OF CLINICAL AND PREVENTIVE CARDIOLOGY 2022. [DOI: 10.4103/jcpc.jcpc_55_21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
10
|
Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE 2021; 2021:9388562. [PMID: 34691230 PMCID: PMC8536432 DOI: 10.1155/2021/9388562] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/06/2021] [Accepted: 09/24/2021] [Indexed: 11/29/2022]
Abstract
Objective To explore the effect of dapagliflozin on cardiac function, inflammation, and cardiovascular outcome in patients with ST-segment elevation myocardial infarction (STEMI) combined with type 2 diabetes (T2DM) after percutaneous coronary intervention (PCI). Methods 70 patients with STEMI and T2DM were divided into the control group (n = 35) and the observation group (n = 35). Before surgery, patients in both groups were given conventional treatments such as coronary expansion, antiplatelet, anticoagulation, and thrombolysis, and PCI was performed. After the operation, both groups were given conventional antiplatelet, anticoagulation, lipid-lowering, and hypoglycemic treatments. On this basis, the observation group was treated with dapagliflozin tablets for 24 weeks. We observe and compare the left ventricular end-diastolic diameter (LVEDD), left ventricular end-systolic diameter (LVESD) and left ventricular ejection fraction (LVEF), myocardial enzyme spectrum, inflammatory reaction, and occurrence of adverse cardiovascular events (MACE) of the two groups of patients before and after treatment. Results After treatment, the LVEDD and LVESD of the two groups were lower than those before treatment, and the observation group was lower than the control group (P < 0.05). The LVEF of both groups was higher than that before treatment, and the observation group was higher than the control group (P < 0.05). After treatment, the levels of two groups' patients' creatine kinase (CK), creatine kinase isoenzyme (CK-MB), and troponin I (cTnI) were all lower than those before treatment, and the observation group patients were all lower than the control group (P < 0.05). After treatment, the levels of serum myeloperoxidase (MPO), C-reactive protein (CRP), interleukin 6 (IL-6), and tumor necrosis factor-α (TNF-α) in the two groups were all lower than those before treatment, and the observation group patients were all lower than the control group (P < 0.05). After treatment, there was no statistical difference between the two groups of patients in cardiogenic death, recurrent myocardial infarction, and other adverse cardiovascular events (P > 0.05). But, the incidence of severe arrhythmia and heart failure in the observation group were both lower than those in the control group (P < 0.05). Kaplan–Meier survival curve analysis showed that the median survival time without MACE in the observation group was higher than that in the control group (P < 0.05). Conclusion Dapagliflozin treatment for patients with STEMI combined with T2DM after PCI can improve cardiac function to certain extent, reduce inflammation, and will reduce the incidence of adverse cardiovascular outcomes.
Collapse
|